{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:24:36Z","timestamp":1792016676294,"version":"4.4.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Committee for Aid and Education in Neurochemistry, International Society for Neurochemistry","award":["1B-Dr.Olajide-ISNCAEN-April2017"],"award-info":[{"award-number":["1B-Dr.Olajide-ISNCAEN-April2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12031-020-01747-w","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T16:02:39Z","timestamp":1610121759000},"page":"1205-1220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-2837","authenticated-orcid":false,"given":"Olayemi Joseph","family":"Olajide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail Tayo","family":"Gbadamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Olusola","family":"Yawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope","family":"Arogundade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folashade Susan","family":"Lewu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehinde Yomi","family":"Ogunrinola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun Olaniyi","family":"Adigun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olawande","family":"Bamisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leviticus Ogbenevurinrin","family":"Arietarhire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olushola Oladapo","family":"Oluyomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumayowa Kolawole","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukayat","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnaemeka Tobechukwu","family":"Asogwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Adeyemi","family":"Adeniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"1747_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.nbd.2005.02.008","volume":"20","author":"CG Almeida","year":"2005","unstructured":"Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK (2005) Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20:187\u2013198. https:\/\/doi.org\/10.1016\/j.nbd.2005.02.008","journal-title":"Neurobiol Dis"},{"key":"1747_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0143-4160(03)00141-6","volume":"34","author":"M Arundine","year":"2003","unstructured":"Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34:325\u2013337. https:\/\/doi.org\/10.1016\/S0143-4160(03)00141-6","journal-title":"Cell Calcium"},{"key":"1747_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nn.2719","volume":"14","author":"\u00c1 Bay\u00e9s","year":"2011","unstructured":"Bay\u00e9s \u00c1, Van De Lagemaat LN, Collins MO et al (2011) Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat Neurosci 14:19\u201321. https:\/\/doi.org\/10.1038\/nn.2719","journal-title":"Nat Neurosci"},{"key":"1747_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fncel.2015.00278","volume":"9","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, Carrillo-de Sauvage M-A, Ceyz\u00e9riat K, Escartin C (2015) Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci 9:278. https:\/\/doi.org\/10.3389\/fncel.2015.00278","journal-title":"Front Cell Neurosci"},{"key":"1747_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11064-010-0371-4","volume":"36","author":"MJ Berridge","year":"2011","unstructured":"Berridge MJ (2011) Calcium signalling and Alzheimer\u2019s disease. Neurochem Res 36:1149\u20131156. https:\/\/doi.org\/10.1007\/s11064-010-0371-4","journal-title":"Neurochem Res"},{"key":"1747_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","volume":"17","author":"DA Butterfield","year":"2003","unstructured":"Butterfield DA, Pocernich CB (2003) The glutamatergic system and Alzheimer\u2019s disease. CNS Drugs 17:641\u2013652. https:\/\/doi.org\/10.2165\/00023210-200317090-00004","journal-title":"CNS Drugs"},{"key":"1747_CR7","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.1523\/JNEUROSCI.1697-05.2005","volume":"25","author":"M Buttini","year":"2005","unstructured":"Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, Johnson-Wood K, Khan K, Seubert P, Freedman S, Schenk D, Games D (2005) \u03b2-Amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer\u2019s disease. J Neurosci 25:9096\u20139101. https:\/\/doi.org\/10.1523\/JNEUROSCI.1697-05.2005","journal-title":"J Neurosci"},{"key":"1747_CR8","doi-asserted-by":"crossref","unstructured":"Campos-Pea V, Antonio M (2014) Alzheimer disease: the role of A\u03b2 in the glutamatergic system. In: Neurochemistry","DOI":"10.5772\/57367"},{"key":"1747_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Mobley WC (2019) Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Front Neurosci 13:659","journal-title":"Front Neurosci"},{"key":"1747_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3233\/JAD-2010-1396","volume":"20","author":"TF Chen","year":"2010","unstructured":"Chen TF, Huang RFS, Lin SE, Lu JF, Tang MC, Chiu MJ (2010) Folic acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer\u2019s disease transgenic model. J Alzheimers Dis 20:607\u2013615. https:\/\/doi.org\/10.3233\/JAD-2010-1396","journal-title":"J Alzheimers Dis"},{"key":"1747_CR11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.neuropharm.2008.04.003","volume":"54","author":"C Chipana","year":"2008","unstructured":"Chipana C, Torres I, Camarasa J et al (2008) Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents. Neuropharmacology 54:1254\u20131263. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.04.003","journal-title":"Neuropharmacology"},{"key":"1747_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/157015912804143522","volume":"10","author":"A Contestabile","year":"2012","unstructured":"Contestabile A, Monti B, Polazzi E (2012) Neuronal-glial interactions define the role of nitric oxide in neural functional processes. Curr Neuropharmacol 10:303\u2013310. https:\/\/doi.org\/10.2174\/157015912804143522","journal-title":"Curr Neuropharmacol"},{"key":"1747_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-16522-6_4","volume":"228","author":"V Costa","year":"2015","unstructured":"Costa V, Lugert S, Jagasia R (2015) Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers. Handb Exp Pharmacol 228:99\u2013155. https:\/\/doi.org\/10.1007\/978-3-319-16522-6_4","journal-title":"Handb Exp Pharmacol"},{"key":"1747_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuropharm.2013.10.018","volume":"79","author":"SE Counts","year":"2014","unstructured":"Counts SE, Alldred MJ, Che S, Ginsberg SD, Mufson EJ (2014) Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology 79:172\u2013179. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.018","journal-title":"Neuropharmacology"},{"key":"1747_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","volume":"167","author":"W Danysz","year":"2012","unstructured":"Danysz W, Parsons CG (2012) Alzheimer\u2019s disease, \u03b2-amyloid, glutamate, NMDA receptors and memantine - searching for the connections. Br J Pharmacol 167:324\u2013352","journal-title":"Br J Pharmacol"},{"key":"1747_CR16","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","volume":"285","author":"A Demuro","year":"2010","unstructured":"Demuro A, Parker I, Stutzmann GE (2010) Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 285:12463\u201312468","journal-title":"J Biol Chem"},{"key":"1747_CR17","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1523\/JNEUROSCI.5980-08.2009","volume":"29","author":"A Deshpande","year":"2009","unstructured":"Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J (2009) A role for synaptic zinc in activity-dependent a\u03b2 oligomer formation and accumulation at excitatory synapses. J Neurosci 29:4004\u20134015. https:\/\/doi.org\/10.1523\/JNEUROSCI.5980-08.2009","journal-title":"J Neurosci"},{"key":"1747_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/156720507779939788","volume":"4","author":"Q Ding","year":"2007","unstructured":"Ding Q, Dimayuga E, Keller JN (2007) Oxidative damage, protein synthesis, and protein degradation in Alzheimer\u2019s disease. Curr Alzheimer Res 4:73\u201379. https:\/\/doi.org\/10.2174\/156720507779939788","journal-title":"Curr Alzheimer Res"},{"key":"1747_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","volume":"30","author":"XX Dong","year":"2009","unstructured":"Dong XX, Wang Y, Qin ZH (2009) Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin 30:379\u2013387","journal-title":"Acta Pharmacol Sin"},{"key":"1747_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/j.1471-4159.1987.tb10014.x","volume":"49","author":"JA Dykens","year":"1987","unstructured":"Dykens JA, Stern A, Trenkner E (1987) Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J Neurochem 49:1222\u20131228. https:\/\/doi.org\/10.1111\/j.1471-4159.1987.tb10014.x","journal-title":"J Neurochem"},{"key":"1747_CR21","doi-asserted-by":"crossref","unstructured":"Facchinetti R, Bronzuoli MR, Scuderi C (2018) An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid \u03b2-peptide (1\u201342). In: Methods in Molecular Biology,","DOI":"10.1007\/978-1-4939-7571-6_25"},{"key":"1747_CR22","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3389\/fneur.2019.01312","volume":"10","author":"L Fan","year":"2020","unstructured":"Fan L, Mao C, Hu X et al (2020) New insights into the pathogenesis of Alzheimer\u2019s disease. Front Neurol 10:1312","journal-title":"Front Neurol"},{"key":"1747_CR23","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1523\/JNEUROSCI.0482-13.2013","volume":"33","author":"CP Figueiredo","year":"2013","unstructured":"Figueiredo CP, Clarke JR, Ledo JH, Ribeiro FC, Costa CV, Melo HM, Mota-Sales AP, Saraiva LM, Klein WL, Sebollela A, de Felice FG, Ferreira ST (2013) Memantine rescues transient cognitive impairment caused by high-molecular-weight A\u03b2 oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J Neurosci 33:9626\u20139634. https:\/\/doi.org\/10.1523\/JNEUROSCI.0482-13.2013","journal-title":"J Neurosci"},{"key":"1747_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.physbeh.2011.05.023","volume":"104","author":"M Filali","year":"2011","unstructured":"Filali M, Lalonde R, Rivest S (2011) Anomalies in social behaviors and exploratory activities in an APPswe\/PS1 mouse model of Alzheimer\u2019s disease. Physiol Behav 104:880\u2013885. https:\/\/doi.org\/10.1016\/j.physbeh.2011.05.023","journal-title":"Physiol Behav"},{"key":"1747_CR25","doi-asserted-by":"publisher","first-page":"175909141985554","DOI":"10.1177\/1759091419855541","volume":"11","author":"CA Findley","year":"2019","unstructured":"Findley CA, Bartke A, Hascup KN, Hascup ER (2019) Amyloid Beta-related alterations to glutamate signaling dynamics during Alzheimer\u2019s disease progression. ASN Neuro 11:1759091419855541","journal-title":"ASN Neuro"},{"key":"1747_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/610813","volume":"2015","author":"R Fischer","year":"2015","unstructured":"Fischer R, Maier O (2015) Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxidative Med Cell Longev 2015:1\u201318","journal-title":"Oxidative Med Cell Longev"},{"key":"1747_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/s1092852900014164","volume":"10","author":"PT Francis","year":"2005","unstructured":"Francis PT (2005) The interplay of neurotransmitters in Alzheimer\u2019s disease. CNS Spectr 10:6\u20139. https:\/\/doi.org\/10.1017\/s1092852900014164","journal-title":"CNS Spectr"},{"key":"1747_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0300-9084(02)01381-0","volume":"84","author":"H Friberg","year":"2002","unstructured":"Friberg H, Wieloch T (2002) Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84:241\u2013250","journal-title":"Biochimie"},{"key":"1747_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ceca.2012.02.008","volume":"52","author":"C Giorgi","year":"2012","unstructured":"Giorgi C, Baldassari F, Bononi A, Bonora M, de Marchi E, Marchi S, Missiroli S, Patergnani S, Rimessi A, Suski JM, Wieckowski MR, Pinton P (2012) Mitochondrial Ca2+ and apoptosis. Cell Calcium 52:36\u201343. https:\/\/doi.org\/10.1016\/j.ceca.2012.02.008","journal-title":"Cell Calcium"},{"key":"1747_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2004.02.005","volume":"63","author":"R Gittins","year":"2004","unstructured":"Gittins R, Harrison PJ (2004) Neuronal density, size and shape in the human anterior cingulate cortex: a comparison of Nissl and NeuN staining. Brain Res Bull 63:155\u2013160. https:\/\/doi.org\/10.1016\/j.brainresbull.2004.02.005","journal-title":"Brain Res Bull"},{"key":"1747_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/1533317510382893","volume":"25","author":"Y Gong","year":"2010","unstructured":"Gong Y, Lippa CF (2010) Review: disruption of the postsynaptic density in Alzheimer\u2019s disease and other neurodegenerative dementias. Am J Alzheimers Dis Other Dement 25:547","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"1747_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682\u2013696","journal-title":"Nat Rev Neurosci"},{"key":"1747_CR33","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1167\/iovs.08-2103","volume":"50","author":"WA Hare","year":"2009","unstructured":"Hare WA, Wheeler L (2009) Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine. Investig Ophthalmol Vis Sci 50:2940. https:\/\/doi.org\/10.1167\/iovs.08-2103","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1747_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1582-4934.2009.00976.x","volume":"14","author":"M Hermes","year":"2010","unstructured":"Hermes M, Eichhoff G, Garaschuk O (2010) Intracellular calcium signalling in Alzheimer\u2019s disease. J Cell Mol Med 14:30\u201341","journal-title":"J Cell Mol Med"},{"key":"1747_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnins.2016.00178","volume":"10","author":"C Hollands","year":"2016","unstructured":"Hollands C, Bartolotti N, Lazarov O (2016) Alzheimer\u2019s disease and hippocampal adult neurogenesis; exploring shared mechanisms. Front Neurosci 10:178. https:\/\/doi.org\/10.3389\/fnins.2016.00178","journal-title":"Front Neurosci"},{"key":"1747_CR36","doi-asserted-by":"publisher","first-page":"AN20110031","DOI":"10.1042\/AN20110031","volume":"4","author":"KA Hosie","year":"2012","unstructured":"Hosie KA, King AE, Blizzard CA, Vickers JC, Dickson TC (2012) Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model. ASN Neuro 4:AN20110031. https:\/\/doi.org\/10.1042\/AN20110031","journal-title":"ASN Neuro"},{"key":"1747_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.arr.2010.05.003","volume":"9","author":"CHL Hung","year":"2010","unstructured":"Hung CHL, Ho YS, Chang RCC (2010) Modulation of mitochondrial calcium as a pharmacological target for Alzheimer\u2019s disease. Ageing Res Rev 9:447\u2013456","journal-title":"Ageing Res Rev"},{"key":"1747_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","volume":"45","author":"MR Hynd","year":"2004","unstructured":"Hynd MR, Scott HL, Dodd PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease. Neurochem Int 45:583\u2013595","journal-title":"Neurochem Int"},{"key":"1747_CR39","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1074\/mcp.M400045-MCP200","volume":"3","author":"BA Jordan","year":"2004","unstructured":"Jordan BA, Fernholz BD, Boussac M, Xu C, Grigorean G, Ziff EB, Neubert TA (2004) Identification and verification of novel rodent postsynaptic density proteins. Mol Cell Proteomics 3:857\u2013871. https:\/\/doi.org\/10.1074\/mcp.M400045-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"1747_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.neurobiolaging.2008.08.009","volume":"31","author":"D Kabogo","year":"2010","unstructured":"Kabogo D, Rauw G, Amritraj A, Baker G, Kar S (2010) \u03b2-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices. Neurobiol Aging 31:1164\u20131172. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.08.009","journal-title":"Neurobiol Aging"},{"key":"1747_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1538\/expanim.60.481","volume":"60","author":"S Kawai","year":"2011","unstructured":"Kawai S, Takagi Y, Kaneko S, Kurosawa T (2011) Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp Anim 60:481\u2013487. https:\/\/doi.org\/10.1538\/expanim.60.481","journal-title":"Exp Anim"},{"key":"1747_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","volume":"179","author":"JNC Kew","year":"2005","unstructured":"Kew JNC, Kemp JA (2005) Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179:4","journal-title":"Psychopharmacology"},{"key":"1747_CR43","doi-asserted-by":"crossref","unstructured":"Lewerenz J, Maher P (2015) Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front Neurosci 9","DOI":"10.3389\/fnins.2015.00469"},{"key":"1747_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1091\/mbc.E05","volume":"125","author":"DW-C Li","year":"2005","unstructured":"Li DW-C (2005) Calcium-activated RAF\/MEK\/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by B-crystallin through inhibition of RAS activation. Mol Biol Cell 125:351\u2013369. https:\/\/doi.org\/10.1091\/mbc.E05","journal-title":"Mol Biol Cell"},{"key":"1747_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3969\/j.issn.1673-5374.2013.01.006","volume":"8","author":"FS Li","year":"2013","unstructured":"Li FS, Chen XW, Wang FM et al (2013) Chronic pre-treatment with memantine prevents amyloid-beta protein-mediated long-term potentiation disruption. Neural Regen Res 8:49. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2013.01.006","journal-title":"Neural Regen Res"},{"key":"1747_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/112_2014_19","volume":"167","author":"D Lim","year":"2014","unstructured":"Lim D, Ronco V, Grolla AA et al (2014) Glial calcium signalling in Alzheimer\u2019s disease. Rev Physiol Biochem Pharmacol 167:45\u201366. https:\/\/doi.org\/10.1007\/112_2014_19","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"1747_CR47","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrn2229","volume":"8","author":"SA Lipton","year":"2007","unstructured":"Lipton SA (2007) Pathologically activated therapeutics for neuroprotection. Nat Rev Neurosci 8:803","journal-title":"Nat Rev Neurosci"},{"key":"1747_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/JAD-2010-100948","volume":"22","author":"J Liu","year":"2010","unstructured":"Liu J, Chang L, Roselli F, Almeida OFX, Gao X, Wang X, Yew DT, Wu Y (2010) Amyloid-\u03b2 induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J Alzheimers Dis 22:541\u2013556. https:\/\/doi.org\/10.3233\/JAD-2010-100948","journal-title":"J Alzheimers Dis"},{"key":"1747_CR49","first-page":"803","volume":"8","author":"J Liu","year":"2019","unstructured":"Liu J, Chang L, Song Y et al (2019) The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci 8:803","journal-title":"Front Neurosci"},{"key":"1747_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6701324","volume":"2016","author":"S Magi","year":"2016","unstructured":"Magi S, Castaldo P, Macr\u00ec ML, Maiolino M, Matteucci A, Bastioli G, Gratteri S, Amoroso S, Lariccia V (2016) Intracellular calcium dysregulation: implications for Alzheimer\u2019s disease. Biomed Res Int 2016:1\u201314. https:\/\/doi.org\/10.1155\/2016\/6701324","journal-title":"Biomed Res Int"},{"key":"1747_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-4-20","volume":"4","author":"P Marambaud","year":"2009","unstructured":"Marambaud P, Dreses-Werringloer U, Vingtdeux V (2009) Calcium signaling in neurodegeneration. Mol Neurodegener 4:20","journal-title":"Mol Neurodegener"},{"key":"1747_CR52","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/j.1476-5381.2011.01646.x","volume":"165","author":"M Mezler","year":"2012","unstructured":"Mezler M, Barghorn S, Schoemaker H, Gross G, Nimmrich V (2012) A ??-amyloid oligomer directly modulates P\/Q-type calcium currents in Xenopus oocytes. Br J Pharmacol 165:1572\u20131583. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01646.x","journal-title":"Br J Pharmacol"},{"key":"1747_CR53","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","volume":"958","author":"JJ Miguel-Hidalgo","year":"2002","unstructured":"Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G (2002) Neuroprotection by memantine against neurodegeneration induced by \u03b2-amyloid(1-40). Brain Res 958:210\u2013221. https:\/\/doi.org\/10.1016\/S0006-8993(02)03731-9","journal-title":"Brain Res"},{"key":"1747_CR54","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.1523\/JNEUROSCI.1199-10.2010","volume":"30","author":"S Mitterreiter","year":"2010","unstructured":"Mitterreiter S, Page RM, Kamp F, Hopson J, Winkler E, Ha HR, Hamid R, Herms J, Mayer TU, Nelson DJ, Steiner H, Stahl T, Zeitschel U, Rossner S, Haass C, Lichtenthaler SF (2010) Bepridil and amiodarone simultaneously target the Alzheimer\u2019s disease beta- and gamma-secretase via distinct mechanisms. J Neurosci 30:8974\u20138983. https:\/\/doi.org\/10.1523\/JNEUROSCI.1199-10.2010","journal-title":"J Neurosci"},{"key":"1747_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-2010-101263","volume":"23","author":"M Moon","year":"2011","unstructured":"Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, Oh MS, Mook-Jung I (2011) Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-\u03b21-42 oligomer-injected mice. J Alzheimers Dis 23:147\u2013159. https:\/\/doi.org\/10.3233\/JAD-2010-101263","journal-title":"J Alzheimers Dis"},{"key":"1747_CR56","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","volume":"60","author":"F Nicoletti","year":"2011","unstructured":"Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60:1017\u20131041","journal-title":"Neuropharmacology"},{"key":"1747_CR57","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/bph.12240","volume":"169","author":"V Nimmrich","year":"2013","unstructured":"Nimmrich V, Eckert A (2013) Calcium channel blockers and dementia. Br J Pharmacol 169:1203\u20131210","journal-title":"Br J Pharmacol"},{"key":"1747_CR58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11011-013-9446-7","volume":"29","author":"OM Ogundele","year":"2014","unstructured":"Ogundele OM, Omoaghe AO, Ajonijebu DC, Ojo AA, Fabiyi TD, Olajide OJ, Falode DT, Adeniyi PA (2014) Glia activation and its role in oxidative stress. Metab Brain Dis 29:483\u2013493. https:\/\/doi.org\/10.1007\/s11011-013-9446-7","journal-title":"Metab Brain Dis"},{"key":"1747_CR59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.etap.2017.02.010","volume":"50","author":"OJ Olajide","year":"2017","unstructured":"Olajide OJ, Yawson EO, Gbadamosi IT, Arogundade TT, Lambe E, Obasi K, Lawal IT, Ibrahim A, Ogunrinola KY (2017) Ascorbic acid ameliorates behavioural deficits and neuropathological alterations in rat model of Alzheimer\u2019s disease. Environ Toxicol Pharmacol 50:200\u2013211. https:\/\/doi.org\/10.1016\/j.etap.2017.02.010","journal-title":"Environ Toxicol Pharmacol"},{"key":"1747_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.etap.2018.07.005","volume":"62","author":"OJ Olajide","year":"2018","unstructured":"Olajide OJ, Fatoye JO, Idowu OF et al (2018) Reversal of behavioral decline and neuropathology by a complex vitamin supplement involves modulation of key neurochemical stressors. Environ Toxicol Pharmacol 62:120\u2013131. https:\/\/doi.org\/10.1016\/j.etap.2018.07.005","journal-title":"Environ Toxicol Pharmacol"},{"key":"1747_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0304-3940(86)90121-7","volume":"65","author":"JW Olney","year":"1986","unstructured":"Olney JW, Price MT, Samson L, Labruyere J (1986) The role of specific ions in glutamate neurotoxicity. Neurosci Lett 65:65\u201371. https:\/\/doi.org\/10.1016\/0304-3940(86)90121-7","journal-title":"Neurosci Lett"},{"key":"1747_CR62","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/wcs.1304","volume":"5","author":"CA Oomen","year":"2014","unstructured":"Oomen CA, Bekinschtein P, Kent BA, Saksida LM, Bussey TJ (2014) Adult hippocampal neurogenesis and its role in cognition. Wiley Interdiscip Rev Cogn Sci 5:573\u2013587","journal-title":"Wiley Interdiscip Rev Cogn Sci"},{"key":"1747_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuint.2008.06.005","volume":"53","author":"M P\u00e1k\u00e1ski","year":"2008","unstructured":"P\u00e1k\u00e1ski M, K\u00e1lm\u00e1n J (2008) Interactions between the amyloid and cholinergic mechanisms in Alzheimer\u2019s disease. Neurochem Int 53:103\u2013111","journal-title":"Neurochem Int"},{"key":"1747_CR64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, St\u00f6ffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse. Neuropharmacology 53:699\u2013723","journal-title":"Neuropharmacology"},{"key":"1747_CR65","unstructured":"Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. Acad press San Diego 3rd:"},{"key":"1747_CR66","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-2012-112192","volume":"30","author":"J Pearson-Leary","year":"2012","unstructured":"Pearson-Leary J, McNay EC (2012) Intrahippocampal administration of amyloid-\u03b21-42 oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism. J Alzheimers Dis 30:413\u2013422. https:\/\/doi.org\/10.3233\/JAD-2012-112192","journal-title":"J Alzheimers Dis"},{"key":"1747_CR67","doi-asserted-by":"publisher","unstructured":"Plassman BL, Langa KM, Fisher GG, et al (2007) Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. https:\/\/doi.org\/10.1159\/000109998","DOI":"10.1159\/000109998"},{"key":"1747_CR68","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","volume":"483","author":"E Popugaeva","year":"2017","unstructured":"Popugaeva E, Pchitskaya E, Bezprozvanny I (2017) Dysregulation of neuronal calcium homeostasis in Alzheimer\u2019s disease \u2013 a therapeutic opportunity? Biochem Biophys Res Commun 483:998\u20131004","journal-title":"Biochem Biophys Res Commun"},{"key":"1747_CR69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","volume":"148","author":"P Raina","year":"2008","unstructured":"Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 148:379\u2013397","journal-title":"Ann Intern Med"},{"key":"1747_CR70","doi-asserted-by":"publisher","first-page":"e2935","DOI":"10.1371\/journal.pone.0002935","volume":"3","author":"JJ Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A (2008) Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer\u2019s disease. PLoS One 3:e2935. https:\/\/doi.org\/10.1371\/journal.pone.0002935","journal-title":"PLoS One"},{"key":"1747_CR71","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/cdd.2008.172","volume":"16","author":"J Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez J, Olabarria M, Chvatal A, Verkhratsky A (2009) Astroglia in dementia and Alzheimer\u2019s disease. Cell Death Differ 16:378\u2013385. https:\/\/doi.org\/10.1038\/cdd.2008.172","journal-title":"Cell Death Differ"},{"key":"1747_CR72","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1089\/ars.2013.5745","volume":"21","author":"AI Rojo","year":"2014","unstructured":"Rojo AI, McBean G, Cindric M, Egea J, L\u00f3pez MG, Rada P, Zarkovic N, Cuadrado A (2014) Redox control of microglial function: molecular mechanisms and functional significance. Antioxid Redox Signal 21:1766\u20131801. https:\/\/doi.org\/10.1089\/ars.2013.5745","journal-title":"Antioxid Redox Signal"},{"key":"1747_CR73","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","volume":"25","author":"F Roselli","year":"2005","unstructured":"Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, Morabito M, Almeida OF (2005) Soluble \u03b2-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 25:11061\u201311070. https:\/\/doi.org\/10.1523\/JNEUROSCI.3034-05.2005","journal-title":"J Neurosci"},{"key":"1747_CR74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14336\/AD.2014.0423","volume":"6","author":"CC Rudy","year":"2015","unstructured":"Rudy CC, Hunsberger HC, Weitzner DS, Reed MN (2015) The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer\u2019s disease. Aging Dis 6:131","journal-title":"Aging Dis"},{"key":"1747_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/526912","volume":"2015","author":"K Salgado-Puga","year":"2015","unstructured":"Salgado-Puga K, Prado-Alcal\u00e1 RA, Pe\u00f1a-Ortega F (2015) Amyloid \u03b2 enhances typical rodent behavior while it impairs contextual memory consolidation. Behav Neurol 2015:1\u201312. https:\/\/doi.org\/10.1155\/2015\/526912","journal-title":"Behav Neurol"},{"key":"1747_CR76","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000464422","volume":"24","author":"A Sanabria-Castro","year":"2017","unstructured":"Sanabria-Castro A, Alvarado-Echeverr\u00eda I, Monge-Bonilla C (2017) Molecular pathogenesis of alzheimer\u2019s disease: an update. Ann Neurosci 24:46","journal-title":"Ann Neurosci"},{"key":"1747_CR77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1515\/revneuro-2013-0056","volume":"25","author":"P Saravanaraman","year":"2014","unstructured":"Saravanaraman P, Chinnadurai RK, Boopathy R (2014) Why calcium channel blockers could be an elite choice in the treatment of Alzheimer\u2019s disease: a comprehensive review of evidences. Rev Neurosci 25:231\u2013246. https:\/\/doi.org\/10.1515\/revneuro-2013-0056","journal-title":"Rev Neurosci"},{"key":"1747_CR78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1517\/14728222.2012.664135","volume":"16","author":"U Saxena","year":"2012","unstructured":"Saxena U (2012) Bioenergetics failure in neurodegenerative diseases: back to the future. Expert Opin Ther Targets 16:351\u2013354. https:\/\/doi.org\/10.1517\/14728222.2012.664135","journal-title":"Expert Opin Ther Targets"},{"key":"1747_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-008-1092-0","volume":"198","author":"EL Schaeffer","year":"2008","unstructured":"Schaeffer EL, Gattaz WF (2008) Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology 198:1\u201327","journal-title":"Psychopharmacology"},{"key":"1747_CR80","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221:555\u2013563","journal-title":"Behav Brain Res"},{"issue":"80","key":"1747_CR81","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298(80):789\u2013791","journal-title":"Science"},{"key":"1747_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","volume":"122","author":"CY Shao","year":"2011","unstructured":"Shao CY, Mirra SS, Sait HBR, Sacktor TC, Sigurdsson EM (2011) Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A\u03b2 and tau pathology in transgenic mouse models of Alzheimer\u2019s disease. Acta Neuropathol 122:285\u2013292. https:\/\/doi.org\/10.1007\/s00401-011-0843-x","journal-title":"Acta Neuropathol"},{"key":"1747_CR83","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","volume":"51","author":"AL Sheldon","year":"2007","unstructured":"Sheldon AL, Robinson MB (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 51:333\u2013355","journal-title":"Neurochem Int"},{"key":"1747_CR84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1590\/S0100-879X2003000200004","volume":"36","author":"SS Smaili","year":"2003","unstructured":"Smaili SS, Hsu TT, Carvalho ACP et al (2003) Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling. Braz J Med Biol Res 36:183\u2013190","journal-title":"Braz J Med Biol Res"},{"key":"1747_CR85","first-page":"347","volume":"2","author":"RH Swerdlow","year":"2007","unstructured":"Swerdlow RH (2007) Pathogenesis of Alzheimer\u2019s disease. Clin Interv Aging 2:347\u2013359","journal-title":"Clin Interv Aging"},{"key":"1747_CR86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3969\/j.issn.1673-5374.2012.02.010","volume":"7","author":"Y Tan","year":"2012","unstructured":"Tan Y, Deng Y, Qing H (2012) Calcium channel blockers and Alzheimer\u2019s disease. Neural Regen Res 7:137\u2013140. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.02.010","journal-title":"Neural Regen Res"},{"key":"1747_CR87","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","volume":"49","author":"L Texid\u00f3","year":"2011","unstructured":"Texid\u00f3 L, Mart\u00edn-Satu\u00e9 M, Alberdi E, Solsona C, Matute C (2011) Amyloid \u03b2 peptide oligomers directly activate NMDA receptors. Cell Calcium 49:184\u2013190. https:\/\/doi.org\/10.1016\/j.ceca.2011.02.001","journal-title":"Cell Calcium"},{"key":"1747_CR88","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405\u2013496","journal-title":"Pharmacol Rev"},{"key":"1747_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S-I, Lipton SA, Xu H (2014) Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener 9:1\u201312. https:\/\/doi.org\/10.1186\/1750-1326-9-48","journal-title":"Mol Neurodegener"},{"key":"1747_CR90","doi-asserted-by":"publisher","unstructured":"Tucci P, Mhillaj E, Morgese MG, Colaianna M, Zotti M, Schiavone S, Cicerale M, Trezza V, Campolongo P, Cuomo V, Trabace L (2014) Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats. Front Behav Neurosci 8. https:\/\/doi.org\/10.3389\/fnbeh.2014.00332","DOI":"10.3389\/fnbeh.2014.00332"},{"key":"1747_CR91","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1038\/cddis.2012.194","volume":"4","author":"A Vaarmann","year":"2013","unstructured":"Vaarmann A, Kovac S, Holmstr\u00f6m KM et al (2013) Dopamine protects neurons against glutamate-induced excitotoxicity. Cell Death Dis 4:e455. https:\/\/doi.org\/10.1038\/cddis.2012.194","journal-title":"Cell Death Dis"},{"key":"1747_CR92","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. J Alzheimers Dis 57:1041","journal-title":"J Alzheimers Dis"},{"key":"1747_CR93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fnins.2010.00194","volume":"4","author":"JM Wang","year":"2010","unstructured":"Wang JM, Sun C (2010) Calcium and neurogenesis in Alzheimer\u2019s disease. Front Neurosci 4:194. https:\/\/doi.org\/10.3389\/fnins.2010.00194","journal-title":"Front Neurosci"},{"key":"1747_CR94","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fphar.2019.01084","volume":"10","author":"LS Wang","year":"2019","unstructured":"Wang LS, Tao X, Liu XM, Zhou YF, Zhang MD, Liao YH, Pan RL, Chang Q (2019) Cajaninstilbene acid ameliorates cognitive impairment induced by intrahippocampal injection of amyloid-\u03b21-42 oligomers. Front Pharmacol 10:1084. https:\/\/doi.org\/10.3389\/fphar.2019.01084","journal-title":"Front Pharmacol"},{"key":"1747_CR95","doi-asserted-by":"publisher","unstructured":"Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, van Eldik LJ (2014) Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5. https:\/\/doi.org\/10.3389\/fgene.2014.00088","DOI":"10.3389\/fgene.2014.00088"},{"key":"1747_CR96","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0006-8993(80)90837-9","volume":"182","author":"HV Wheal","year":"1980","unstructured":"Wheal HV, Miller JJ (1980) Pharmacological identification of acetylcholine and glutamate excitatory systems in the dentate gyrus of the rat. Brain Res 182:145\u2013155. https:\/\/doi.org\/10.1016\/0006-8993(80)90837-9","journal-title":"Brain Res"},{"key":"1747_CR97","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbr.2017.09.006","volume":"336","author":"LS Whyte","year":"2018","unstructured":"Whyte LS, Hemsley KM, Lau AA, Hassiotis S, Saito T, Saido TC, Hopwood JJ, Sargeant TJ (2018) Reduction in open field activity in the absence of memory deficits in the AppNL\u2212G\u2212F knock-in mouse model of Alzheimer\u2019s disease. Behav Brain Res 336:177\u2013181. https:\/\/doi.org\/10.1016\/j.bbr.2017.09.006","journal-title":"Behav Brain Res"},{"key":"1747_CR98","doi-asserted-by":"publisher","unstructured":"Wong RS, Cechetto DF, Whitehead SN (2016) Assessing the effects of acute amyloid \u03b2 oligomer exposure in the rat. Int J Mol Sci 17. https:\/\/doi.org\/10.3390\/ijms17091390","DOI":"10.3390\/ijms17091390"},{"key":"1747_CR99","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","volume":"37","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li P, Feng J, Wu M (2016) Dysfunction of NMDA receptors in Alzheimer\u2019s disease. Neurol Sci 37:1039\u20131047","journal-title":"Neurol Sci"},{"key":"1747_CR100","first-page":"457079","volume":"2011","author":"J Zhu","year":"2011","unstructured":"Zhu J, Zheng XY, Zhang HL, Luo Q (2011) Kainic acid-induced neurodegenerative model: potentials and limitations. J Biomed Biotechnol 2011:457079","journal-title":"J Biomed Biotechnol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01747-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01747-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:01:12Z","timestamp":1620039672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01747-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1747"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01747-w","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"17 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}